|| Checking for direct PDF access through Ovid
To assess results of treatment for anal fistulae.The study included 400 patients (275 men) with fistulae treated during the period May 2006 to September 2009. The average age was 46 years (12-89). Ninety-five patients had inflammatory bowel disease of which 89 had Crohn's disease. 305 patients had fistulae of cryptoglandular or other origin.Of the 400 patients, 107 received treatment with SCP, 139 received treatment with fistulotomy, 10 with advancement flap and 10 with V.A.C. 134 were under investigation or had ongoing drainage with vessel loops. 107 patients received treatment with SCPs, some more than once. Of these, 34 patients had Crohn's disease of which two had rectovaginal fistulae (RVF). Seventy-three patients had fistulae of cryptoglandular origin, of which four had RVF. The healing of fistulae in the SCP group was 60% of the patients with Crohn's disease and 65% of the patients with cryptoglandular fistulae. The average follow up was 13 months (10-40).Our results suggest that SCP treatment of fistulas have a high healing rate and could be used as first line treatment for high fistulae.